$1.28
2.00% day before yesterday
Nasdaq, Dec 27, 09:50 pm CET
ISIN
NL0015000DX5
Symbol
ATAI
Sector
Industry

ATAI Life Sciences N.V. Stock price

$1.28
-0.45 26.01% 1M
-0.04 3.03% 6M
-0.13 9.22% YTD
-0.27 17.42% 1Y
-6.71 83.98% 3Y
-18.17 93.42% 5Y
-18.17 93.42% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.03 2.40%
ISIN
NL0015000DX5
Symbol
ATAI
Sector
Industry

Key metrics

Market capitalization $214.79m
Enterprise Value $138.28m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 419.03
P/S ratio (TTM) P/S ratio 650.88
P/B ratio (TTM) P/B ratio 1.47
Revenue growth (TTM) Revenue growth -0.90%
Revenue (TTM) Revenue $330.00k
EBIT (operating result TTM) EBIT $-105.88m
Free Cash Flow (TTM) Free Cash Flow $-79.86m
Cash position $100.92m
EPS (TTM) EPS $-0.80
P/E forward negative
P/S forward 414.65
EV/Sales forward 266.95
Short interest 7.97%
Show more

Is ATAI Life Sciences N.V. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

ATAI Life Sciences N.V. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a ATAI Life Sciences N.V. forecast:

7x Buy
100%

Analyst Opinions

7 Analysts have issued a ATAI Life Sciences N.V. forecast:

Buy
100%

Financial data from ATAI Life Sciences N.V.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.33 0.33
0% 0%
100%
- Direct Costs 0.35 0.35
29% 29%
106%
-0.02 -0.02
88% 88%
-6%
- Selling and Administrative Expenses 55 55
7% 7%
16,724%
- Research and Development Expense 50 50
28% 28%
15,248%
-106 -106
18% 18%
-31,979%
- Depreciation and Amortization 0.35 0.35
29% 29%
106%
EBIT (Operating Income) EBIT -106 -106
18% 18%
-32,084%
Net Profit -129 -129
92% 92%
-38,970%

In millions USD.

Don't miss a Thing! We will send you all news about ATAI Life Sciences N.V. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ATAI Life Sciences N.V. Stock News

Positive
Proactive Investors
about one month ago
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) shares should move higher on a slew of Phase 2 and 3 data readouts in 2025 from across its pipeline of innovative psychedelic therapies, analysts at Jefferies. Following the release of atai's third quarter results earlier this week, the analysts repeated their ‘Buy' rating on the stock and awarded it a $5 price target, implying upside of 242% from its s...
Positive
Proactive Investors
about 2 months ago
atai Life Sciences (NASDAQ:ATAI, ETR:9VC), a biopharmaceutical company targeting mental health disorders, advanced its pipeline of innovative therapies during the third quarter of 2024. Notably, the US Food and Drug Administration approved an investigational new drug application for for VLS-01, atai's buccal film formulation of DMT.
Positive
Proactive Investors
about 2 months ago
President-elect Donald Trump's promise that Robert F Kennedy Junior (RFK Jr) will take on a “big role” in shaping health policy could be a positive for psychedelics given RKF Jr's well-documented support of this drug class, analysts at Jefferies believe. “RFK Jr seems positively inclined and sounds motivated to help foster psychedelic drug development,” analysts wrote in a note to clients, noti...
More ATAI Life Sciences N.V. News

Company Profile

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Head office Netherlands
CEO Florian Rao
Employees 83
Founded 2018
Website www.atai.life

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today